Kalahn A. Taylor-Clark, Ph.D., J99, MG01

Kalahn Taylor-Clark, PhD, MPH is the Global Head of Patient Solutions at Sanofi. Dr. Taylor-Clark serves as the strategic patient lead to global business units in the US/EU and China and Emerging Markets, across all therapeutic areas of the company. Her team is responsible for supporting patient-focused risk-benefit analyses, improving digital strategies and new technology use to better capture patients’ perspectives, and translating Real World Evidence (RWE) studies into high impact solutions to improve patient adherence and outcomes. Prior to this post Taylor-Clark served as the US Head of Public Affairs in Cardiometabolic Health. Taylor-Clark’s work has helped the company to develop, measure, amplify and adapt solutions based on key stakeholder input (e.g. providers, patients, scientific societies and policymakers), that align to emphasize increased access to innovation and improved patient-relevant outcomes.

Prior to joining Sanofi, Dr. Taylor-Clark served as a Senior Advisor to the Center for Health Policy, Research and Ethics and Assistant Professor in Health Administration and Policy at George Mason University, where she provided strategic guidance on the development and evaluation of patient and consumer engagement activities for a range of stakeholders, including: private and public payers, hospital and integrated health systems, business groups, and policy leaders. Previously, she served as the Director of Health Policy at the National Partnership for Women and Families, where her primary responsibilities were in providing strategic direction on a range of activities related to delivery system and payment reform, including: quality measurement, reduction of health disparities, patient and consumer engagement in patient-centered care delivery and the effective use of health information technology (HIT) to improve patient-reported outcomes measurement. From 2007-2011, Dr. Taylor-Clark led the Patient-Centeredness and Health Equity Portfolios in the Engelberg Center for Health Care Reform at the Brookings Institution in Washington D.C.

She holds a BA in International Relations from Tufts University, an MPH from Tufts School of Medicine, and a PhD in Health Policy from Harvard University. She serves as President of the Board of Directors at Prevention Institute in Oakland, CA. Dr. Taylor-Clark has also lived in Japan, Ghana and France, and speaks French.

She was re-elected to the Tufts Board of Trustees for a second five-year term on November 6, 2021.

Revised July 2021.